Patent ductus arteriosus: evidence for and against treatment.
about
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitVocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complicationsAre cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone.The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closureImpact of patent ductus arteriosus and subsequent therapy with ibuprofen on the release of S-100B and oxidative stress index in preterm infantsMultiple courses of indomethacin and neonatal outcomes in premature infants.Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after studyPatent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.Current Perspectives on Pathobiology of the Ductus Arteriosus.The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaThe role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trialBedside PDA ligation in premature infants less than 28 weeks and 1000 grams.Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.Cerebellar hemorrhagic injury in premature infants occurs during a vulnerable developmental period and is associated with wider neuropathology.Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?Caffeine impact on neonatal morbidities.Patent ductus arteriosus in the preterm infant: to treat or not to treat?Patent ductus arteriosus: wait and see?Patent ductus arteriosus in infants <29 weeks gestation--outcomes and factors affecting closure.Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.Percutaneous closure of patent arterial ducts in patients from high altitude: a sub-Saharan experience.Patent ductus arteriosus in preterm infant: Basic pathology and when to treat.Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus.Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.Macrolides do not affect the incidence of moderate and severe bronchopulmonary dysplasia in symptomatic ureaplasma-positive infants.Ibuprofen treatment for closure of patent ductus arteriosus is not associated with increased risk of neuropathology.Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants.Early echocardiographic prediction of ductal closure in neonates ≤ 30 weeks gestation.Assessment of myocardial function in preterm infants with patent ductus arteriosus using tissue Doppler imaging.Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
P2860
Q24604121-5A9E507E-88A9-43BC-9A8A-D07B4DB63F4CQ30494339-4589E32D-3416-4BB6-AF43-6D5DA835402BQ33680208-EC172823-425B-4C7D-ADC6-88960C029FA2Q33840349-19BF10AE-C42D-45DD-A323-6C4484B4BBB0Q34018364-1359935F-51A0-48AE-965E-C49C93FABF4DQ34134402-F87CD08A-46E4-446F-8A39-6ED1D1D539E9Q34143373-FD641649-86ED-42CC-90FF-685EEE36EA6BQ34726703-A7595905-EAC0-401E-A015-5759F125B6F5Q34731663-6E4718F1-63AC-4F43-BD56-C8763E9AFE56Q34820620-1F415042-DC2C-4855-AA4B-6C7BEA6B4756Q34846689-4F3858BC-CC36-44DD-952E-E3B4C020027DQ35580251-47915A42-5576-4873-9575-0F214F827501Q35626826-88EE6BCB-3AB6-4B4A-9ABC-C913B2DC13D4Q35834962-8EC3FFA8-6105-4B07-B39A-433E3D3E7BD3Q36484043-47E2F611-F9A4-409A-B2A2-87DFA956E93AQ36695955-86C36CE9-3FFC-46C6-97D5-C2B66D1E2C8DQ36768333-0316FCB6-182C-4934-8A78-136D10E9BEDDQ37258662-00D94BF1-2E82-4567-9B64-BAB0C632CF14Q37311187-5D276474-A553-44B9-BD02-F3EA7C31EE71Q37324451-95AD7CA6-6AD2-4F91-9666-961772BF26E7Q37364820-86C97A12-9E98-4880-B884-3FE644F2B7C1Q37485062-3C917C1D-BB5E-4941-926A-BAF92A3B7945Q37698200-3C30C4D0-7D88-4755-9FF0-14EB93FB297EQ37793063-AAC88DB2-2576-4A01-8501-CD3A66CE80C5Q37793846-2D1D9C4C-3C47-45A9-8AC9-C4C5C1CC0CF7Q37914874-62BBD2A5-6B34-4B50-AD5F-5C5E68FEA187Q37982601-EC910538-BBD0-439A-BCF6-7A66EF8DFC6CQ37998378-43B2D800-90E1-4CC2-BF4B-E7D99C78D1C7Q38630155-5F2ED802-8B50-48FD-91F3-4DFFD480248AQ38919316-E12ED4C7-2BE7-4F7D-8A84-F82FC9EA7BFDQ39835581-EB65611C-558A-43EE-A356-F2471A680A0BQ40398107-F2933C92-2A00-4A63-8F2C-E42FB8BB7986Q40799329-3E3F64B5-8606-498E-B882-EDF1B9014A22Q42105988-3627C8D4-E977-4724-A558-18932A3056F9Q42534997-D1E432DC-F29F-4AED-8335-59CA228FCD0AQ42535520-DB0AAF62-A922-416C-93CA-18A7B8CFE970Q43662777-E14A60CA-A62A-4A24-A6D0-90B6E34B2E70Q44734078-8269EBC3-CE62-4DB8-B344-C121344C40BBQ44832226-8BECF9E3-8D8D-405E-B0AE-837FF80DF284Q45607250-91124AC3-F6AC-4688-B046-CDD9F74B3A03
P2860
Patent ductus arteriosus: evidence for and against treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Patent ductus arteriosus: evidence for and against treatment.
@en
Patent ductus arteriosus: evidence for and against treatment.
@nl
type
label
Patent ductus arteriosus: evidence for and against treatment.
@en
Patent ductus arteriosus: evidence for and against treatment.
@nl
prefLabel
Patent ductus arteriosus: evidence for and against treatment.
@en
Patent ductus arteriosus: evidence for and against treatment.
@nl
P2860
P1476
Patent ductus arteriosus: evidence for and against treatment.
@en
P2093
Nancy Chorne
Ronald I Clyman
P2860
P304
P356
10.1016/J.JPEDS.2006.12.048
P407
P577
2007-03-01T00:00:00Z